J P Gisbert

Summary

Country: Spain

Publications

  1. ncbi Risk assessment and outpatient management in bleeding peptic ulcer
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    J Clin Gastroenterol 40:129-34. 2006
  2. doi Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 28:228-38. 2008
  3. pmc Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Madrid, Spain
    Clin Exp Gastroenterol 5:23-34. 2012
  4. pmc Rescue Therapy for Helicobacter pylori Infection 2012
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, 28006 Madrid, Spain
    Gastroenterol Res Pract 2012:974594. 2012
  5. pmc Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Clin Transl Gastroenterol 4:e32. 2013
  6. doi Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Playa de Mojácar 29 Urb Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 59:383-9. 2014
  7. doi Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Am J Gastroenterol 108:1426-38. 2013
  8. doi Vaccination strategies in patients with IBD
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Diego de Leon 62, Madrid 28006, Spain
    Nat Rev Gastroenterol Hepatol 10:277-85. 2013
  9. ncbi Pathophysiological bases of eosinophilic esophagitis therapy
    Ricardo Moreno-Borque
    Alergología Clínica Servicio de Medicina Interna, Hospital Rey Juan Carlos I, Mostoles, Madrid, Spain
    Inflamm Allergy Drug Targets 12:46-53. 2013
  10. doi Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Am J Gastroenterol 107:1197-204. 2012

Detail Information

Publications146 found, 100 shown here

  1. ncbi Risk assessment and outpatient management in bleeding peptic ulcer
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    J Clin Gastroenterol 40:129-34. 2006
    ....
  2. doi Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 28:228-38. 2008
    ..The long-term efficiacy for thiopurinic drugs in Crohn's disease (CD), and particularly in ulcerative colitis (UC), has been insufficiently studied...
  3. pmc Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Madrid, Spain
    Clin Exp Gastroenterol 5:23-34. 2012
    ..pylori) infection (proton pump inhibitor-clarithromycin-amoxicillin) can easily be converted to non-bismuth quadruple (concomitant) therapy by the addition of a nitroimidazole twice daily...
  4. pmc Rescue Therapy for Helicobacter pylori Infection 2012
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, 28006 Madrid, Spain
    Gastroenterol Res Pract 2012:974594. 2012
    ..Even after two consecutive failures, several studies have demonstrated that H. pylori eradication can finally be achieved in almost all patients if several "rescue" therapies are consecutively given...
  5. pmc Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Clin Transl Gastroenterol 4:e32. 2013
    ..The aim present article addresses the test-and-treat strategy and attempts to provide practical conclusions for the clinician who diagnoses and treats patients with dyspepsia...
  6. doi Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Playa de Mojácar 29 Urb Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 59:383-9. 2014
    ..Helicobacter pylori eradication therapy with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin fails in >20 % of cases. A rescue therapy with PPI-amoxicillin-levofloxacin still fails in >20 % of patients...
  7. doi Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Am J Gastroenterol 108:1426-38. 2013
    ..However, data regarding their safety during pregnancy and breastfeeding are scarce. The aim of this study was to critically review available data on the safety of anti-TNF therapy during pregnancy and breastfeeding in women with IBD...
  8. doi Vaccination strategies in patients with IBD
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Diego de Leon 62, Madrid 28006, Spain
    Nat Rev Gastroenterol Hepatol 10:277-85. 2013
    ..Therefore, vaccination status should be checked and updated upon diagnosis of IBD...
  9. ncbi Pathophysiological bases of eosinophilic esophagitis therapy
    Ricardo Moreno-Borque
    Alergología Clínica Servicio de Medicina Interna, Hospital Rey Juan Carlos I, Mostoles, Madrid, Spain
    Inflamm Allergy Drug Targets 12:46-53. 2013
    ..Prolonged treatment is advised for EoE because it recurs frequently, particularly on discontinuation of therapy. Experimental treatments using immunotherapy are being investigated, but their safety and efficacy are yet to be defined...
  10. doi Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Am J Gastroenterol 107:1197-204. 2012
    ..To evaluate the effect of Helicobacter pylori (H. pylori) eradication on ulcer bleeding recurrence in a prospective, long-term study including 1,000 patients...
  11. doi [Helicobacter pylori-related diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Gastroenterol Hepatol 35:12-25. 2012
    ..Even after three eradication therapies have failed, an empirical rescue therapy (with rifabutin) can be effective. H. pylori reinfection is highly frequent in developing countries, probably due to intrafamilial transmission...
  12. doi [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Espana
    Gastroenterol Hepatol 34:15-26. 2011
    ..Even after three previous H. pylori eradication failures, an empirical fourth-line rescue treatment with rifabutin may be effective...
  13. doi Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Aliment Pharmacol Ther 34:1255-68. 2011
    ..Therefore, it is evident that new strategies to improve first-line treatment are urgently needed...
  14. ncbi Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29 Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Dig Liver Dis 36:253-9. 2004
    ....
  15. ncbi [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Espana
    Gastroenterol Hepatol 31:18-28. 2008
    ..The annual recurrence rate of H. pylori infection is approximately 3% in developed countries and is higher than 10% in developing countries...
  16. doi Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 30:126-37. 2009
    ..Debate exists regarding to whether thiopurine therapy is as effective in ulcerative colitis (UC) as it is in Crohn's disease...
  17. doi Management of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    Curr Med Res Opin 25:2777-84. 2009
    ..To describe the management of gastro-oesophageal reflux disease (GERD) in primary care, as part of the RANGE (Retrospective ANalysis of GERD) study...
  18. ncbi Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis
    Javier P Gisbert
    Servicio de Gastroenterología y Hepatología, Universidad Autonoma de Madrid, Hospital Universitario de la Princesa, Diego de Leon, 62 28006, Madrid, Spain
    J Hepatol 39:620-7. 2003
    ..To conduct a systematic review and meta-analysis on the prevalence of hepatitis C virus (HCV) infection in porphyria cutanea tarda (PCT)...
  19. ncbi [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de la Princesa Universidad Autónoma Madrid Spain
    Med Clin (Barc) 121:1-5. 2003
    ....
  20. ncbi Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 16:89-99. 2004
    ....
  21. doi Sequential therapy for Helicobacter pylori eradication: a critical review
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Clin Gastroenterol 44:313-25. 2010
    ..Alternative treatment regimens for standard triple therapy are urgently needed...
  22. ncbi [Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid España
    Med Clin (Barc) 122:134-5. 2004
    ..Patients and method: pANCA were determined by indirect immunofluorescence and positive results were confirmed by ELISA...
  23. ncbi [Systematic reviews and meta-analyses: how should they be performed, evaluated and used?]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Gastroenterol Hepatol 27:129-49. 2004
  24. ncbi Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29, Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Dig Liver Dis 36:116-20. 2004
    ....
  25. ncbi Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Hepatogastroenterology 51:303-8. 2004
    ..To assess whether H. pylori therapy is significantly better than control therapy in patients with functional dyspepsia, and to assess whether curing the infection relieves symptoms of dyspepsia...
  26. doi Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Dig Liver Dis 42:287-90. 2010
    ..To assess the efficacy and tolerability of Helicobacter pylori first-line treatment (omeprazole-clarithromycin-metronidazole) and second-line rescue option (omeprazole-clarithromycin-levofloxacin) in patients allergic to penicillin...
  27. pmc Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Health Qual Life Outcomes 7:90. 2009
    ..This subanalysis of RANGE determined the impact of GERD on productivity in work and daily life...
  28. ncbi [Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Universidad Autónoma Madrid España
    Gastroenterol Hepatol 29:568-83. 2006
    ....
  29. pmc Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de Princesa, Madrid, Spain, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Spain
    Health Qual Life Outcomes 7:60. 2009
    ..We report the burden of GERD in a large population of patients managed in primary care, in terms of symptoms and impact on patients' daily lives...
  30. doi Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Inflamm Bowel Dis 15:1746-54. 2009
    ..Finally, in patients with Crohn's disease who have undergone ileocolonic resection, those with higher lactoferrin fecal levels might be more prone to postsurgical recurrence...
  31. doi Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Inflamm Bowel Dis 15:1190-8. 2009
    ....
  32. ncbi Systematic review: Infliximab therapy in ulcerative colitis
    J P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, Madrid, Spain
    Aliment Pharmacol Ther 25:19-37. 2007
    ..To perform a systematic review and meta-analysis on the efficacy and tolerance of infliximab in ulcerative colitis...
  33. ncbi Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 23:35-44. 2006
    ..A quadruple therapy has been generally recommended as rescue regimen for Helicobacter pylori eradication failures...
  34. ncbi Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding
    Javier P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Madrid, Spain
    Helicobacter 12:279-86. 2007
    ..To evaluate the effect of Helicobacter pylori eradication on ulcer bleeding recurrence in a prospective, long-term study including more than 400 patients...
  35. ncbi Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    J P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, Playa de Mojácar 29 Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Dig Liver Dis 38:254-9. 2006
    ..To study if there is a correlation between 13C-urea breath test values prior to treatment and the response to first-line and rescue Helicobacter pylori eradication therapies...
  36. ncbi 13C-urea breath test in the management of Helicobacterpylori infection
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29, Urb Bonanza, Boadilla del Monte, Madrid 28669, Spain
    Dig Liver Dis 37:899-906. 2005
    ..pylori infection in patients with upper gastrointestinal bleeding, urea breath test seems not to be negatively influenced by the presence of this complication...
  37. ncbi [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Gastroenterol Hepatol 28:567-75. 2005
  38. ncbi Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin
    J P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Madrid, Spain
    Aliment Pharmacol Ther 22:1041-6. 2005
    ..Helicobacter pylori eradication is a challenge in patients allergic to penicillin, especially those who have failed a first-eradication trial...
  39. ncbi Helicobacter pylori "rescue" therapy after failure of two eradication treatments
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 10:363-72. 2005
    ....
  40. ncbi [Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Med Clin (Barc) 125:301-16. 2005
  41. ncbi Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Ciberehd, Universidad Autonoma, Madrid, Spain
    Aliment Pharmacol Ther 27:346-54. 2008
    ..Several 'rescue' therapies have been recommended to eradicate Helicobacter pylori, but they still fail in >20% of the cases, and these patients constitute a therapeutic dilemma...
  42. pmc "Rescue" regimens after Helicobacter pylori treatment failure
    Javier P Gisbert
    Gastroenterology Unit, Hospital de la Princesa, Madrid, Spain
    World J Gastroenterol 14:5385-402. 2008
    ..Therefore, the attitude in H pylori eradication therapy failure, even after two or more unsuccessful attempts, should be to fight and not to surrender...
  43. ncbi 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 21:1249-53. 2005
    ..Quadruple rescue therapy requires a complex scheme with four drugs...
  44. ncbi Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 21:795-804. 2005
    ....
  45. ncbi [Role of biological markers in inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 30:117-29. 2007
    ..Like calprotectin, fecal lactoferrin is also quantified by a simple and inexpensive ELISA method, although there is considerably less experience with this latter marker...
  46. ncbi Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication
    Javier P Gisbert
    Gastroenterology Unit, La Princesa University Hospital, Autonomous University, School of Pharmacy, Alcala de Henares University, Alcala de Henares, Spain
    J Clin Gastroenterol 40:618-22. 2006
    ..This could be achieved by allowing the drug to remain longer in the stomach using dried hydrogels. Our aim was to evaluate the efficacy of an H. pylori eradication regimen including both amoxicillin and clarithromycin hydrogels...
  47. ncbi [Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments]
    J P Gisbert
    Hospital Ramon y Cajal, Departamento de Medicina, Universidad de Alcala de Henares, Madrid
    Med Clin (Barc) 112:365-7. 1999
    ..To evaluate whether antral biopsies are enough for confirming Helicobacter pylori eradication with the "new" one week triple therapies with omeprazole...
  48. ncbi Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Playa de Mojácar 29, Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Aliment Pharmacol Ther 16:1047-57. 2002
    ..Recently, rifabutin-based rescue therapies have been shown to constitute an encouraging strategy for eradication failures, as they are effective against H. pylori strains resistant to antibiotics...
  49. ncbi Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 13:1303-7. 2001
    ..To evaluate whether eradication therapy is more effective in peptic ulcer disease (PUD) than in non-ulcer dyspepsia (NUD)...
  50. ncbi Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Hepatogastroenterology 48:1383-8. 2001
    ....
  51. ncbi [Study of the validity of "rapid" serology in diagnosing Helicobacter pylori infection]
    J P Gisbert
    Hospital de la Princesa Madrid España
    Aten Primaria 30:501-6. 2002
    ..To evaluate prospectively the validity of a <<rapid>> serology diagnosis method (using capillary blood) in our ambit, taking for reference a combination of standard diagnostic methods...
  52. ncbi Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer
    J P Gisbert
    Department of Gastroenterology, University Hospital La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 15:917-26. 2001
    ..To evaluate whether proton pump inhibitors are more effective than H2-antagonists (H2-A) for the treatment of bleeding peptic ulcer...
  53. ncbi Helicobacter pylori infection, gastric metaplasia in the duodenum and the relationship with ulcer recurrence
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 12:1295-8. 2000
    ..pylori) infection and gastric metaplasia (GM) in the duodenum a large group of patients with duodenal ulcer was evaluated to determine whether these factors are related to the number of ulcer recurrences...
  54. ncbi 13C-urea breath test for the diagnosis of Helicobacter pylori infection: are basal samples necessary?
    J P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 12:1201-5. 2000
    ..g. depending on diet). However, the superiority of this strategy has not been sufficiently demonstrated. The elimination of basal samples in the 13C-UBT protocol would have the advantages of higher simplicity and speed...
  55. ncbi [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]
    J P Gisbert
    Servicio de Gastroenterologia, Hospital Ramon y Cajal, Departamento de Medicina, Universidad de Alcala de Henares, Madrid
    Med Clin (Barc) 112:161-5. 1999
    ..To evaluate the efficacy on H. pylori eradication and on ulcer healing of three one-week triple therapies and to compare their efficacy with that of a dual therapy...
  56. ncbi Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 14:1141-50. 2000
    ..To compare the efficacy of proton pump inhibitor vs. ranitidine bismuth citrate (RBC) with two antibiotics for 1 week in Helicobacter pylori eradication...
  57. ncbi ["Rapid" serology for the diagnosis of Helicobacter pylori infection. Evaluation of its accuracy compared with a gold-standard and its concordance with "classic" serology]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid
    Gastroenterol Hepatol 23:159-64. 2000
    ....
  58. ncbi Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 13:1311-6. 1999
    ..A 'rescue' therapy with a quadruple combination of O, bismuth (B), tetracycline (T) and metronidazole (M) has been recommended...
  59. ncbi Re-treatment after Helicobacter pylori eradication failure
    J P Gisbert
    Department of Gastroenterology, Hospital Ramon y Cajal, Universidad de Alcala de Henares, Madrid, Spain
    Eur J Gastroenterol Hepatol 11:1049-54. 1999
    ..Therefore, our aim was to evaluate the appropriate attitude when eradication therapy fails...
  60. ncbi Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Hepatogastroenterology 46:1023-9. 1999
    ..In conclusion, H. pylori and GERD seem to have, in any case, a "friendly" relationship, although it may be transformed into one of "hate" when PPIs enter the scene...
  61. ncbi Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study
    J P Gisbert
    Department of Gastroenterology, Ramon y Cajal Hospital, University of Alcala de Henares, Madrid, Spain
    Eur J Gastroenterol Hepatol 11:189-200. 1999
    ..Finally, an evaluation was made of the variables influencing gastrin and PG concentration, with particular attention to H. pylori infection and histological lesions of gastric mucosa...
  62. doi Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Aliment Pharmacol Ther 34:1047-62. 2011
    ..Helicobacter pylori infection is the main cause of gastric mucosa-associated lymphoid tissue (MALT) lymphoma...
  63. doi Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain
    J P Gisbert
    Departamento de Gastroenterologia, Hospital Universitario La Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Spain
    J Crohns Colitis 4:567-74. 2010
    ..This knowledge would allow the local evaluation of the situation and the adoption of actions to reduce the existent clinical variability...
  64. pmc Second-line rescue therapy of helicobacter pylori infection
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Therap Adv Gastroenterol 2:331-56. 2009
    ..Therefore, the attitude in H. pylori eradication therapy failure, even after two or more unsuccessful attempts, should be to fight and not to surrender...
  65. ncbi Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
    J P Gisbert
    Servicio de Gastroenterología y Hepatología, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Diego de Leon 62, E 28006 Madrid, Spain
    Aliment Pharmacol Ther 17:17-27. 2003
    ..However, ursodeoxycholic acid may be given when histology reveals bile duct lesions, whereas immunosuppressive therapy should probably be reserved for patients exhibiting interface hepatitis...
  66. ncbi Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigacion Sanitaria, Princesa IP, Madrid, Spain
    Aliment Pharmacol Ther 33:619-33. 2011
    ..Viral hepatitis is a very common infection...
  67. ncbi [Comparison between two 13C-urea breath tests for the diagnosis of Helicobacter pylori infection: isotope ratio mass spectrometer versus infrared spectrometer]
    J P Gisbert
    Servicios de Aparato Digestivo Hospital Universitario de la Princesa Madrid Spain
    Gastroenterol Hepatol 26:141-6. 2003
    ..To compare the accuracy of the breath test using the isotope ratio mass spectrometer (IRMS) versus the nondispersive isotope-selective infrared spectrometer (NDIRS) in the diagnosis of Helicobacter pylori infection...
  68. ncbi [Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review]
    Javier P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid España
    Med Clin (Barc) 120:550-8. 2003
  69. ncbi [Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Rev Clin Esp 202:555-62. 2002
  70. ncbi [Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barretts esophagus]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Med Clin (Barc) 119:217-23. 2002
  71. ncbi Role of partner's infection in reinfection after Helicobacter pylori eradication
    Javier P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Universidad Autonoma de Madrid, Spain
    Eur J Gastroenterol Hepatol 14:865-71. 2002
    ..To evaluate whether the Helicobacter pylori status of the patient's spouse plays a role in reinfection after eradication success, and to assess the possibility of transmission of H. pylori among partners by using molecular methods...
  72. ncbi [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Gastroenterol Hepatol 26:312-24. 2003
  73. ncbi Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment
    J P Gisbert
    Servicio de Aparato Digestivo Hospital de la Princesa Madrid Spain
    Rev Esp Enferm Dig 95:121-6, 115-20. 2003
    ..Our objective was to validate the UBT (TAU-KIT) both as an initial diagnostic method for the detection of H. pylori infection and as a method to confirm eradication...
  74. doi Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gen Pract 15:154-60. 2009
    ..To report on the primary care consultation rates and clinical characteristics of patients with gastro-oesophageal reflux disease (GERD) as part of the RANGE (Retrospective ANalysis of GERD) observational study...
  75. ncbi [Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up]
    F Bermejo
    Servicio de Gastroenterologia, Hospital Ramon y Cajal, Madrid
    Med Clin (Barc) 115:201-4. 2000
    ..To study the influence of Helicobacter pylori eradication on the incidence of ulcer recurrence during 12 months of follow-up in gastric ulcer patients...
  76. ncbi What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis
    X Calvet
    Servei de Medicina, Corporacio Sanitaria Parc Tauli, Sabadell, Spain Servicio de Aparato Digestivo, Hospital de la Princesa, Madrid, Spain
    Aliment Pharmacol Ther 15:1067-76. 2001
    ..Triple therapy with a proton pump inhibitor, clarithromycin and amoxicillin is widely used for H. pylori infection. The appropriate length of treatment remains controversial...
  77. ncbi Third-line rescue therapy with levofloxacin after two H. pylori treatment failures
    Javier P Gisbert
    Hospital de la Princesa, Madrid, Spain
    Am J Gastroenterol 101:243-7. 2006
    ..A rescue therapy still fails in more than 20% of the cases. Our aim was to evaluate the efficacy and tolerability of a third-line levofloxacin-based regimen in patients with two consecutive Helicobacter pylori eradication failures...
  78. ncbi Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients
    Javier P Gisbert
    Hospital de la Princesa, Madrid
    Am J Gastroenterol 103:71-6. 2008
    ..Our aim was to evaluate the efficacy and tolerability of a triple second-line levofloxacin-based regimen in patients with H. pylori eradication failure...
  79. ncbi High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 6:157-62. 2001
    ..CONCLUSION: The combination of Rbc, amoxicillin, clarithromycin and metronidazole for only 5 days represents a promising therapy for H. pylori infection, due to its high efficacy, simple posology, low cost and excellent tolerance...
  80. doi Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication
    J Molina-Infante
    Department of Gastroenterology, Hospital San Pedro de Alcantara, Caceres, Spain
    Aliment Pharmacol Ther 31:1077-84. 2010
    ..Helicobacter pylori eradication rates with standard triple therapy have declined to unacceptable levels...
  81. ncbi Diagnosis of Helicobacter pylori infection by stool antigen determination: a systematic review
    J P Gisbert
    Department of Gastroenterology University Hospital of La Princesa, Madrid, Spain
    Am J Gastroenterol 96:2829-38. 2001
    ..although the true diagnostic accuracy in this group of patients remains to be more fully assessed. Finally, the SA test seems to be a highly cost-effective method for the diagnosis of H. pylori infection...
  82. ncbi Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Gastroenterol 100:1935-40. 2005
    ..To study the efficacy of esomeprazole-based triple therapy in Helicobacter pylori eradication and to evaluate, by a randomized trial, the effect of increasing the dose of esomeprazole or prolonging the treatment...
  83. ncbi Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study
    Francesc Balaguer
    Department of Gastroenterology, Institut de Malalties Digestives i Metaboliques, Hospital Clinic, CIBERehd, IDIBAPS Institut d Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain
    Clin Gastroenterol Hepatol 5:379-87. 2007
    ....
  84. ncbi The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Helicobacter 9:28-38. 2004
    ..To prospectively evaluate the effectiveness of the test-and-treat strategy in a large group of dyspeptic patients in clinical practice...
  85. ncbi Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication?
    J P Gisbert
    Dept of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Scand J Gastroenterol 38:2-9. 2003
  86. ncbi Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis
    Javier P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Am J Gastroenterol 101:848-63. 2006
    ..To perform a systematic review and a meta-analysis of diagnostic accuracy of the different tests aimed to detect Helicobacter pylori infection in patients with upper gastrointestinal bleeding (UGIB)...
  87. ncbi Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
    J P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Aliment Pharmacol Ther 24:1469-74. 2006
    ..In patients with a first eradication failure, a second (rescue) therapy still fails in > 20% of cases...
  88. ncbi Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis
    E Gómez-Domínguez
    Service of Gastroenterology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
    Aliment Pharmacol Ther 27:441-7. 2008
    ..Liver stiffness measurements may have potential for detecting and monitoring hepatic fibrosis in chronic liver disease...
  89. doi Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
    J P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Madrid, Spain
    Aliment Pharmacol Ther 34:604-17. 2011
    ..Traditional standard triple therapy for Helicobacter pylori infection (PPI-clarithromycin-amoxicillin) can easily be converted to non-bismuth quadruple (concomitant) therapy by the addition of a nitroimidazole twice daily...
  90. ncbi Gastric angiogenesis and Helicobacter pylori infection
    I D Pousa
    Service of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Rev Esp Enferm Dig 98:527-41. 2006
    ..In the case of gastric cancer, neoangiogenesis would enhance nutrient and oxygen supply to cancer cells, and thus tumor growth and metastatic spread...
  91. ncbi Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients
    J P Gisbert
    Gastroenterology Units of La Princesa University Hospital, Madrid, Spain
    Aliment Pharmacol Ther 23:713-9. 2006
    ..To study the incidence of Helicobacter pylori recurrence, its chronological aspects, and the variables that might influence it...
  92. ncbi Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection
    J P Gisbert
    Gastroenterology and Hepatology Service, La Princesa University Hospital, 28006 Madrid, Spain
    Aliment Pharmacol Ther 21:653-62. 2005
    ....
  93. ncbi [Treatment of stenosis due to Crohn's disease]
    J P Gisbert
    Servicio de Aparato Digestivo Hospital Universitario de La Princesa Madrid Spain
    Gastroenterol Hepatol 25:560-9. 2002
  94. ncbi Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs
    J P Gisbert
    Dept of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Scand J Gastroenterol 36:717-24. 2001
    ..Our aim was to study the prevalence of H. pylori in bleeding duodenal ulcer (DU), with both invasive and non-invasive methods, and to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs)...
  95. ncbi [Breath tests in the diagnosis of gastrointestinal diseases]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 28:407-16. 2005
    ....
  96. ncbi Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Aliment Pharmacol Ther 16:1203-8. 2002
    ..pylori-positive stenosis, whereas dilation or surgery should be reserved for patients who do not respond to such medical therapy...
  97. ncbi [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease]
    J P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Gastroenterol Hepatol 25:401-15. 2002
  98. ncbi Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study
    J P Gisbert
    Servicio de Gastroenterologia, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Gastroenterol Hepatol 28:615-8. 2005
    ..Eradication was confirmed with 13C-urea breath test 6-8 weeks later, when stool samples were analyzed by polyclonal (Premier-Platinum-HpSATM), monoclonal (Amplified-IDEIATM-HpStARTM), and rapid test (ImmunoCard-STAT-HpSATM)...
  99. ncbi Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer
    J P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    Aliment Pharmacol Ther 19:617-29. 2004
    ..To perform a meta-analysis comparing the efficacy of Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer...
  100. ncbi Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study
    J P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Universidad Autonoma, Madrid, Spain
    Clin Infect Dis 30:976-80. 2000
    ..5 months after antibiotic therapy is completed) can be used as a noninvasive, simple, and inexpensive method to confirm H. pylori eradication...
  101. ncbi 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary?
    J P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Dig Liver Dis 32:20-4. 2000
    ..Thus, our aim was to compare 13C-urea breath test with and without citric acid solution, to evaluate whether 13C-urea breath test can also achieve favourable results when the test meal is omitted...